Journal of Blood & Lymph

Bortoluzzi C

Publications

• Research Article
  Effects of Mesoglycan Treatment in the Prevention of Venous Thrombosis after Superficial Vein Surgery
  Author(s): Kontothanassis D, Daniele Bissacco, Oberto S, De Zolt P, Camporese G and Bortoluzzi CKontothanassis D, Daniele Bissacco, Oberto S, De Zolt P, Camporese G and Bortoluzzi C
  
  Aim: To demonstrate the effectiveness of a two months treatment with Mesoglycan after superficial vein surgery in the prevention of superficial vein thrombosis (SVT) and deep vein thrombosis (DVT). Methods: From January 2014 to April 2015, all patients underwent superficial vein surgery were enrolled and analyzed. Clinical examination through CEAP class identification, Venous Clinical Severity Score (VCSS), and color Duplex ultrasound scanning (CDUS) were performed before treatment, two days post-operatively and at the 2 month follow-up time. Prophylaxis with heparin was given for 1 week after treatment. Mesoglycan 50 mg tablet BID was continued for 2 months. Primary endpoint was Mesoglycan side effect rate. Secondary endpoints were postoperative deep and/or superficial vein thrombosis (DVT and SVT, respectively), endovenous heat induced thromb.. Read More»
  DOI: 10.4172/2165-7831.1000231

  Abstract PDF